New Division Dedicated to Multilingual Localization Solutions in the Life Sciences Sector

Beijing, China (February 26, 2008) – CSOFT International, Inc., a leading provider of multilingual localization, testing and outsourced software development, announced today the official launch of MedL10N (www.medl10n.com) a dedicated division focusing on the delivery of multilingual translation and localization solutions for the Life Sciences industry.

“Addressing the unique localization requirements of the Life Sciences industry, MedL10N has developed customized processes and best-of-breed technology to achieve better quality with improved efficiency,” said Shunee Yee, President and CEO of CSOFT. “MedL10N will enable CSOFT to better support our clients and assist them with meeting the regulatory pressures they face.”

MedL10N’s mission is to provide pharmaceutical, medical device and biotech companies with quality and industry focused localization and translation solutions consistent with international regulatory requirements.

Powered by experienced linguistic professionals and medical experts around the world, MedL10N enables clients in the pharmaceutical, medical devices and biotech fields to develop and deploy products in global markets quickly and competitively.

“By leveraging CSOFT’s extensive localization experience, MedL10N provides targeted localization solutions that address the distinct translation requirements of the Life Sciences industry– technical accuracy and regulatory compliance,” continued Yee. “CSOFT’s in-depth knowledge of the medical field and the highly efficient localization methodologies employed sets us apart from others in our space.”

CSOFT is headquartered in Beijing and maintains international offices in Boston, San Francisco, Chicago, Memphis, Japan, Australia, Canada and Germany.

For more information about MedL10N, please visit: http://www.medl10n.com. For more information on CSOFT, please visit: www.csoftintl.com.